Christian Wölbeling

09.10.2025 • Topics • Chemistry

Pharma 4.0 — the Key Enabler for Successful Digital Transformation in Pharma – part 2

Part 2: Digital transformation - 10 Years after the Start of Pharma 4.0

02.10.2025 • Topics • Chemistry

Pharma 4.0 – the Key Enabler for Successful Digital Transformation in Pharma

Part 1: Building a Business Case for Pharma 4.0

Top-Feature

Evonik Operations GmbH (Hanau)

20 Years of CHEManager International

Interview

Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

ISPE D/A/CH e.V.

Christian Wölbeling

Pharma 4.0 — the Key Enabler for Successful Digital Transformation in Pharma – part 2

Pharma 4.0 – the Key Enabler for Successful Digital Transformation in Pharma

Top-Feature

Biobased Feedstocks as a Roadmap to Defossilization

A successful concept on course for expansion — maintenance Munich 2025

Digitalization in the Chemical Industry

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Advanced Recycling Conference 2025: New Paths to the Circular Economy

20 Years of CHEManager International

Interview

Stability in Motion

Newsletter & e-edition